Chiral Quest patents novel chiral catalyst
Chiral Quest parent VioQuest Pharmaceuticals has been awarded a US patent covering the use of novel catalysts to increase the efficiency of chiral amine and amino acid synthesis.
Archives for October 13, 2004
Nanofibres to deliver drugs to wounds
Researchers in the US have reported the initial development of a biodegradable polymeric nanofibre-based antibiotic delivery system, which promotes the healing process even in hard-to-treat wounds.
Patient-controlled pumps increase risk of harm
Giving patients control of analgesic medications through the use of controllable pumps improves pain relief, but raises the risk of harm more than 3.5 times, according to the US Pharmacopeia's Centre for the Advancement of Patient Safety.
People on the move
In-Pharmatechnologist's periodic round up of personnel moves in the pharmaceutical sector includes a crop of new chief executives and senior managers across the pharmachem, drug delivery and biomanufacturing sectors.
Baby boomers want the supplements pharma giants are making
The older generation is leading the consumption of nutritional supplements in the US and the aging baby boomers are the population to invest in, according to a new report, that also shows the supplement industry is now firmly in the hands of pharma...
Aradigm hails Intraject a success
Novel approaches to administering drugs took a step forward after Aradigm announced positive trial results in its Intraject needle-free delivery system, which paves the way for a viable alternative to the standard needle injection.